Game‑changing pan‑RAS data from RevMed drives RAS into its next phase
Incyte, BMS & Amgen tackle resistance with new ASCO data
View the 2026 Attendee List

Building Effective Combination Strategies Across the Complexity of RAS-Driven Cancers

Building Effective Combination Strategies Across the Complexity of RAS-Driven Cancers

12:55 pm - Tuesday 8th September 2026